Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison

Acta Neurologica Taiwanica

Volumn 21, Issue 2, 2012, Pages 64-73

  Chang, Ya Ting ^a   Chang, Chiung Chih ^a   Lin, Hung Sheng ^a   Huang, Chi Wei ^a   Chang, Wen Neng ^a   Lui, Chun Chung ^a   Lee, Chen Chang ^a   Lin, Yu Ting ^a   Chen, Chang Hung ^a   Chen, Nai Ching ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Alzheimer's disease; Cognitive ability screening instrument; Mini Mental state examination; Montreal cognitive assessment; White matter hyperintensities

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; ATTENTION; COGNITIVE ASSESSMENT SCREENING INSTRUMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGICAL RATING SCALE; SCREENING; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TAIWAN; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; TAIWAN;

EID: 84865800902     PISSN: 1028768X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53: 695-699.
2. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
3. Dick JP, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, Marsden CD. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry 1984; 47: 496-499.
4. Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord 2008; 23:1043-1046.
5. Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord 2010; 25: 401-404.
6. Wong A, Xiong YY, Kwan PW, Chan AY, Lam WW, Wang K, Chu WC, Nyenhuis DL, Nasreddine Z, Wong LK, Mok VC. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009; 28: 81-87.
7. Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008; 23: 297-299.
8. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006; 66: 23-29.
9. Darvesh S, Freedman M. Subcortical dementia: a neurobehavioral approach. Brain Cogn 1996; 31: 230-249.
10. Huang CW, Chang WN, Lui CC, Chen CF, Lu CH, Wang YL, Chen C, Juang YY, Lin YT, Tu MC, Chang CC. Impacts of hyper-homocysteinemia and white matter hyperintensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. Curr Alzheimer Res 2010; 7: 527-533.
11. Tu MC, Huang CW, Chen NC, Chang WN, Lui CC, Chen CF, Chen C, Wang YL, Lin YT, Chang CC. Hyperhomocysteinemia in Alzheimer Dementia Patients and Cognitive Decline after 6 Months Follow-up Period. Acta Neurol Taiwan 2010; 19: 164-173.
12. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988; 38: 359-364.
13. Rockwood K, Strang D, MacKnight C, Downer R, Morris JC. Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc 2000; 48: 558-559.
14. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7: 486-488.
15. Liu HC, Chou P, Lin KN, Wang SJ, Fuh JL, Lin HC, Liu CY, Wu GS, Larson EB, White LR, Graves AB, Teng EL. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med 1994; 24: 763-770.
16. Lin KN, Wang PN, Liu CY, Chen WT, Lee YC, Liu HC. Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia. Dement Geriatr Cogn Disord 2002; 14: 176-182.
17. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993; 50: 818-824.
18. Luis CA, Keegan AP, Mullan M. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry 2009; 24: 197-201.
19. Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011; 77: 1272-1275.
20. Tsai CF, Lee WJ, Wang SJ, Shia BC, Nasreddine Z, Fuh JL. Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychogeriatr 2011: 1-8.
21. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry 2007; 52: 329-332.
22. Duro D, Simoes MR, Ponciano E, Santana I. Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis. J Neurol 2010; 257: 728-734.
23. Wen HB, Zhang ZX, Niu FS, Li L. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Zhonghua Nei Ke Za Zhi 2008; 47: 36-39.
24. Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, Inagaki H, Iwasa H, Ura C, Yatomi N, Ishii K, Tokumaru AM, Homma A, Nasreddine Z, Shinkai S. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 2010;10: 225-232.
25. Lee JY, Dong Woo L, Cho SJ, Na DL, Hong Jin J, Kim SK, You Ra L, Youn JH, Kwon M, Lee JH, Maeng Je C. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2008; 21: 104-110.
26. Athilingam P, King KB, Burgin SW, Ackerman M, Cushman LA, Chen L. Montreal Cognitive Assessment and Mini-Mental Status Examination compared as cognitive screening tools in heart failure. Heart Lung 2011; 40: 521-529.
27. Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, Caviness JN, Adler CH. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord 2011; 31: 126-131.
28. Tu MC, Huang CW, Chen NC, Chang WN, Lui CC, Chen CF, Chen C, Wang YL, Lin YT, Chang CC. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurol Taiwan 2010; 19: 168-177.
29. Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 2011; 7: 208-244.